Global Premature Ejaculation Treatment Market- Allergan, Innovus Pharmaceutical, GlaxoSmithKline
Global Premature Ejaculation Treatment Market was valued at around USD 1.2 billion in 2015 and is expected to reach USD 2.6 billion by 2022, growing at a CAGR of around 11.6% during the forecast period of 2016 to 2022.
Pune, India – July 6, 2017 /MarketersMedia/ —
Introduction:
Premature ejaculation is uncontrolled ejaculation either before or shortly after sexual penetration. It happens with minimal sexual stimulation and before the person wishes. It may result in unsatisfactory sex for both partners. This can increase the anxiety that may add to the problem.
Do Inquiry Before Purchasing Report Here: https://market.biz/report/global-premature-ejaculation-treatment-market-gm/108100/#inquiry
The global market for premature ejaculation treatment was valued at around USD 1.2 billion in 2015 and is expected to reach USD 2.6 billion by 2022, growing at a CAGR of around 11.6% during the forecast period of 2016 to 2022. Premature ejaculation is uncontrolled ejaculation either before or shortly after sexual penetration. It happens with minimal sexual stimulation and before the person wishes. It may result in unsatisfactory sex for both partners. This can increase the anxiety that may add to the problem. It is one of the most common forms of male sexual dysfunction. It has probably affected every man at some point in his life.
Geographically, North America is the leading contributor to the market and is expected to retain its position during the forecast period due to the presence of large number of geriatric population, and large base of patients with sexual disorders. However, Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, technological advancements, and growing awareness among the population about the treatment options available in the market.
The companies covered in the Global Premature Ejaculation Treatment Market report:
1) Janssen Pharmaceutica N. V. (a pharmaceutical company of Johnson and Johnson)
2) Plethora Solutions Holdings PLC
3) Akorn Pharmaceuticals
4) Absorption Pharmaceuticals
5) Allergan
6) Innovus Pharmaceuticals
7) GlaxoSmithKline
8) Pfizer
Request For Sample Report Here: https://market.biz/report/global-premature-ejaculation-treatment-market-gm/108100/#requestforsample
About Us:
Market.Biz consists of a highly motivated team of young and experienced individuals who are detail-oriented and highly focused on providing clients with the information they need. Information is king in the business world, and we specialize in providing that.
Referal News Network: http://incrediblenews24.com
Contact Info:
Name: Lawrence John
Email: inquiry@market.biz
Organization: Market.Biz
Address: S no. 51/14 First Floor, Office Number 4, Vishwa Arcade, Near Navale Lawns, Pune, Maharashtra, India 411041.
Phone: +1(857)2390696
For more information, please visit https://market.biz/report/global-premature-ejaculation-treatment-market-gm/108100/
Source: MarketersMedia
Release ID: 215085
Copyright © 1999-2013 SproutNews.com
